SENSEI BIOTHERAPEUTICS INC (SNSE) Stock Analyst Earnings Estimates
NASDAQ:SNSE - Nasdaq - US81728A1088 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A 304.42% | N/A 10.64% | N/A 75.09% | |||||||
| EBITDA YoY % growth | -12.7M | -12.36M 2.68% | -18.51M -49.76% | -36.8M -98.81% | -48.84M -32.72% | -35.713M 26.88% | N/A 4.99% | N/A -1.95% | N/A -8.77% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -12.74M | -12.43M 2.43% | -18.72M -50.60% | -37.49M -100.27% | -50.19M -33.88% | -37.064M 26.15% | N/A 10.15% | N/A 13.39% | N/A -17.27% | N/A -83.15% | N/A 2.51% | N/A 25.81% | N/A 75.88% | N/A 403.09% | N/A 174.25% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.36 71.39% | -1.58 -16.18% | -1.22 22.78% | N/A 4.29% | N/A 29.68% | N/A 15.90% | N/A -106.79% | N/A 42.14% | N/A 29.63% | N/A 85.96% | N/A 675.00% | N/A 126.09% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 3.95% | -0.22 29.87% | -0.13 52.64% | -0.13 56.03% | -0.13 55.75% |
| Revenue Q2Q % growth | N/A | N/A | N/A | ||
| EBITDA Q2Q % growth | -9.466M -39.38% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.199M -0.70% | -6.493M 25.62% | -6.885M 11.58% | -6.694M 14.43% | -6.949M 15.24% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.29 -3.57% | -0.32 | 0.03 | 9.02% |
| Q2 2024 Q2Q % growth | -0.28 9.68% | -0.29 | 0.01 | 4.85% |
| Q1 2024 Q2Q % growth | -0.32 3.03% | -0.28 | -0.04 | -14.08% |
| Q4 2023 Q2Q % growth | -0.30 25.00% | -0.31 | 0.01 | 4.40% |
| Q3 2023 Q2Q % growth | -0.28 36.36% | -0.35 | 0.07 | 19.02% |
| Q2 2023 Q2Q % growth | -0.31 8.82% | -0.34 | 0.03 | 8.04% |
| Q1 2023 Q2Q % growth | -0.33 17.50% | -0.36 | 0.03 | 9.12% |
| Q4 2022 Q2Q % growth | -0.40 -33.33% | -0.41 | 0.01 | 1.96% |
| Q3 2022 Q2Q % growth | -0.44 -37.50% | -0.38 | -0.06 | -16.59% |
| Q2 2022 Q2Q % growth | -0.34 -6.25% | -0.40 | 0.06 | 15.61% |
| Q1 2022 Q2Q % growth | -0.40 4.76% | -0.36 | -0.04 | -12.04% |
| Q4 2021 Q2Q % growth | -0.30 88.93% | -0.35 | 0.05 | 13.49% |
| Q3 2021 Q2Q % growth | -0.32 | -0.25 | -0.07 | -29.37% |
| Q2 2021 Q2Q % growth | -0.32 | -0.30 | -0.02 | -8.06% |
| Q1 2021 Q2Q % growth | -0.42 | -0.31 | -0.11 | -35.45% |
| Q4 2020 Q2Q % growth | -2.71 | -3.02 | 0.31 | 10.24% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.88% | 1.48% | 0.17% | -2.88% |
| Revenue | N/A | N/A | N/A | N/A |